CRISPR patent landscape

Since 2014, we’ve monitored, analyzed and classified new CRISPR patent publications worldwide in a dedicated patent database in order to give an overall, independent overview of the IP situation. This unique work and expertise¬† has been quoted by Nature, The Scientist, Bloomberg, Fortune and Quartz among others.

Learn more on our latest CRISPR patent analytics services and patent landscape here.